ReviewPublished 1 October 2026Gd-IgA1-targeting therapy in IgA nephropathy ~what is pathogenic Gd-IgA1?~Kazuaki Mori · Yoshihito Nihei · Yusuke SuzukiFrontiers in Nephrologydoi 10.3389/fneph.2026.1977707
ReviewPublished 24 September 2026Complement biomarkers in IgA nephropathy: current insights and clinical relevanceAltynay Balmukhanova · Chee Eng Chan · Jonathan BarrattFrontiers in Nephrologydoi 10.3389/fneph.2026.1918450
Original ResearchPublished 21 September 2026The lactate dehydrogenase-to-albumin ratio is independently associated with moderate-to-severe tubulointerstitial fibrosis in patients with IgA nephropathyLuli Zheng · Guokai YangFrontiers in Nephrologydoi 10.3389/fneph.2026.1931478
Case ReportPublished 8 September 2026Case Report: Advanced IgA nephropathy with psoriasis and a complex clinicopathologic courseLerui Wang · Minxia Li · Boyang Xu · Dan ShuFrontiers in Nephrologydoi 10.3389/fneph.2026.1932773
Systematic ReviewPublished 12 August 2026Impact of hematuria on long term kidney outcomes in adults with immunoglobulin A nephropathy: a systematic literature review and meta-analysisJoel Iff · Ankit Shah · Rajeshwari Nair · Mirko Fillbrunn · Ogo Egbuna · Manish Maski · Rui Huang · Dumingu Aparna Gomes · Edward Tuttle · Whitney Longstaff · Janice Stricker-Shaver · Beth BarberFrontiers in Nephrologydoi 10.3389/fneph.2026.1899597
Original ResearchPublished 11 August 2026Development and validation of a routine urinalysis-based risk stratification model for IgA nephropathy in a multicenter real-world hospital populationChi Wang · Wan He · QingYuan Zheng · Yuan Zhong · Meng Tang · ChunYing Zhang · Yong HeFrontiers in Nephrologydoi 10.3389/fneph.2026.1826486
Case ReportPublished 13 July 2026Case Report: Renal sarcoidosis coexisting with membranous and IgA nephropathy, a very uncommon associationMariel Hernández-Pérez · Daniel Enos · Rocío Contreras Faundez · Joaquín Ramírez Herrera · Pablo Tapia Riedemann · Gonzalo P. Méndez · Jorge Gutiérrez VenturaFrontiers in Nephrologydoi 10.3389/fneph.2026.1809424
